Your browser doesn't support javascript.
loading
Olanzapine-Associated Pisa Syndrome in an Autistic Adolescent.
Guler, Hasan Ali; Turkoglu, Serhat; Cetin, Fatih Hilmi; Ucar, Halit Necmi; Erdogan, Yakup.
Afiliación
  • Guler HA; Department of Child and Adolescent Psychiatry, Faculty of Medicine, Selcuk University, Konya, Turkey.
  • Turkoglu S; Department of Child and Adolescent Psychiatry, Faculty of Medicine, Selcuk University, Konya, Turkey.
  • Cetin FH; Department of Child and Adolescent Psychiatry, Faculty of Medicine, Selcuk University, Konya, Turkey.
  • Ucar HN; Department of Child and Adolescent Psychiatry, Faculty of Medicine, Selcuk University, Konya, Turkey.
  • Erdogan Y; Department of Child and Adolescent Psychiatry, Bitlis State Hospital, Bitlis, Turkey.
Clin Neuropharmacol ; 43(2): 48-49, 2020.
Article en En | MEDLINE | ID: mdl-32097169
OBJECTIVES: The objective of this study is to report a case of Pisa syndrome due to olanzapine use in an autistic adolescent. METHODS: The patient was a 12-year-old adolescent girl who was taking olanzapine for autism-related behavioral problems. Abnormal posture and balance problems appeared in the third month of olanzapine treatment. The patient was diagnosed as having Pisa syndrome after clinical evaluation. Biperiden was started on the patient whose complaints continued despite olanzapine treatment was stopped. Patient's complaints regressed with biperiden treatment. RESULTS: According to our knowledge, there is no an autistic adolescent case of Pisa syndrome previously reported in the literature. Further studies are needed to clarify the etiology and treatment of Pisa syndrome. CONCLUSIONS: In patients with balance problems and abnormal posture as a result of olanzapine use, the clinician should keep in mind Pisa syndrome.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno Autístico / Antipsicóticos / Olanzapina Tipo de estudio: Risk_factors_studies Límite: Adolescent / Female / Humans Idioma: En Revista: Clin Neuropharmacol Año: 2020 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trastorno Autístico / Antipsicóticos / Olanzapina Tipo de estudio: Risk_factors_studies Límite: Adolescent / Female / Humans Idioma: En Revista: Clin Neuropharmacol Año: 2020 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Estados Unidos